Matthew F. Fisher

Beech Hill Road, S10 2RX
Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis.

Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.

Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.

Journal: British journal of cancer

Published: November 26, 2025

Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha-Amidating Monooxygenase Activity in Synovial Fibroblasts.

Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha-Amidating Monooxygenase Activity in Synovial Fibroblasts.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 01, 2025

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy.

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy.

Journal: Journal for immunotherapy of cancer

Published: July 10, 2024

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.

Journal: EBioMedicine

Published: July 07, 2023

Rac1 controls cell turnover and reversibility of the involution process in postpartum mammary glands.

Rac1 controls cell turnover and reversibility of the involution process in postpartum mammary glands.

Journal: PLoS biology

Published: February 11, 2022

Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: Analysis of a large cohort of eighty-one alkaptonuria patients.

Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: Analysis of a large cohort of eighty-one alkaptonuria patients.

Journal: Molecular genetics and metabolism

Published: January 05, 2021

Identifying critical source areas using multiple methods for effective diffuse pollution mitigation.

Identifying critical source areas using multiple methods for effective diffuse pollution mitigation.

Journal: Journal of environmental management

Published: October 12, 2018

Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy.

Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy.

Journal: ChemMedChem

Published: August 22, 2018

Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone.

Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone.

Journal: Data in brief

Published: July 24, 2018

Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.

Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.

Journal: Molecular genetics and metabolism

Published: March 28, 2018

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo.

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo.

Journal: PloS one

Published: January 16, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026